BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1857142)

  • 41. Ph-positive chronic myeloid leukemia mimicking essential thrombocythemia and terminating into megakaryoblastic blast crisis: report of two cases with molecular studies.
    Cervantes F; Urbano-Ispizua A; Villamor N; Feliu E; Milla F; Lopez-Guillermo A; Ribera JM; Granada I; Vives-Corrons JL; Montserrat E
    Leukemia; 1993 Feb; 7(2):327-30. PubMed ID: 8426485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac tamponade in the blastic crisis of chronic myelogenous leukemia.
    Yamauchi K; Arimori S; Nagao T
    Tokai J Exp Clin Med; 1992 Jul; 17(2):89-93. PubMed ID: 1440659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sudden extramedullary blast crisis of chronic myeloid leukemia manifesting as T-cell lymphoblastic lymphoma.
    Wei J; Huang M; Wang Y; Zhou J
    Onkologie; 2013; 36(3):119-22. PubMed ID: 23486000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic myelocytic leukemia terminating in blast cell crisis with lymphoblastic characteristics.
    Walters TR; Minowada J; Tsubota T; Kataoka K; Han T
    Pediatrics; 1978 Nov; 62(5):795-800. PubMed ID: 281667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chronic myeloid leukemia beginning as thrombocythemia. Analysis of 5 cases].
    Cervantes F; Alcorta I; Bosch F; Vives-Corrons JL; Rozman C
    Sangre (Barc); 1992 Feb; 37(1):1-3. PubMed ID: 1585231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ABL amplification in a patient with lymphoid blast crisis of chronic myelogenous leukaemia.
    Kenner L; Beham-Schmid C; Kerbl R; Schmidt HH; Sill H; Hoefler G
    Virchows Arch; 1999 Mar; 434(3):255-7. PubMed ID: 10190307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 'Lymphoid' blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features.
    Cervantes F; Villamor N; Esteve J; Montoto S; Rives S; Rozman C; Montserrat E
    Br J Haematol; 1998 Jan; 100(1):123-8. PubMed ID: 9450800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytogenetic and immunogenotypic alterations of blast crisis cells in chronic myelogenous leukemia independently linked to immunophenotypic expression.
    Murakami T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Tauchi T; Nakazawa S; Kimura N; Toyama K
    Cancer Genet Cytogenet; 1994 Jan; 72(1):48-54. PubMed ID: 8111739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia.
    Breccia M; Serrao A; Salaroli A; Loglisci G; Zacheo I; Alimena G
    Br J Haematol; 2012 Dec; 159(5):612-3. PubMed ID: 23043319
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chronic myelocytic leukemia in children].
    Poliakov VE
    Feldsher Akush; 1991 Nov; 56(11):23-9. PubMed ID: 1807975
    [No Abstract]   [Full Text] [Related]  

  • 51. Possible effect of medroxyprogesterone acetate (MPA) in lymphoid blast crisis of chronic myelogenous leukemia.
    Fink M
    Ann Hematol; 1994 Feb; 68(2):89-90. PubMed ID: 8148420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypercalcemia as the presenting feature of t-cell lymphoid blast crisis of ph-positive chronic myeloid leukemia.
    Nadal E; Cervantes F; RosiƱol L; Talarn C; Montserrat E
    Leuk Lymphoma; 2001 Mar; 41(1-2):203-6. PubMed ID: 11342375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Lymphoid blast crisis in chronic myelogenous leukemia].
    Ranft K
    Dtsch Med Wochenschr; 1984 Jan; 109(1):20-3. PubMed ID: 6581956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T-lymphoid blast crisis in chronic myeloid leukemia.
    Advani SH; Malhotra H; Kadam PR; Iyer RS; Nanjangud G; Balsara B; Saikia T; Gopal R; Nair CN
    Am J Hematol; 1991 Feb; 36(2):86-92. PubMed ID: 2012070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping--experience in 60 patients.
    Saikia T; Advani S; Dasgupta A; Ramakrishnan G; Nair C; Gladstone B; Kumar MS; Badrinath Y; Dhond S
    Leuk Res; 1988; 12(6):499-506. PubMed ID: 3165486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotypic changes in a case of blast crisis of CML: characterization by TdT, cytochemistry, and cytogenetics.
    Paietta E; Schwarzmeier JD
    Scand J Haematol; 1981 Oct; 27(4):241-6. PubMed ID: 6955937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small, abnormal B lymphoid blast populations in chronic myelogenous leukemia at diagnosis: Does this finding indicate an accelerated course?
    Soma L; Oehler VG; Ding C; Cherian S
    Cytometry B Clin Cytom; 2016 Sep; 90(5):440-8. PubMed ID: 26800237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzyme negative blastic transformation of chronic myeloproliferative disorders: immunophenotyping of the blastic cell population.
    Matolcsy A; Izer I; Magyarlaki T; Baranyay F
    Haematologia (Budap); 1991; 24(1):27-37. PubMed ID: 1813360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sudden blast phase in pediatric chronic myeloid leukemia-chronic phase with abnormal lymphoid blasts detected by flow cytometry at diagnosis: Can it be considered a warning sign?
    Vijayasekharan K; Chatterjee G; Ramanathan S; Narula G; Tembhare P; Subramanian PG; Patkar N; Gujral S; Shetty D; Banavali S
    Cytometry B Clin Cytom; 2021 May; 100(3):345-351. PubMed ID: 33030302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Idiopathic hypereosinophilic syndrome and "eosinophilic leukemia".
    Cassi E; De Paoli A; Fava S; Luoni M; Tosi A; Turri C; Grimi E
    Haematologica; 1992; 77(5):430-2. PubMed ID: 1483595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.